Graney & King, LLC Incyte Corp Transaction History
Graney & King, LLC
- $132 Billion
- Q4 2024
A detailed history of Graney & King, LLC transactions in Incyte Corp stock. As of the latest transaction made, Graney & King, LLC holds 50 shares of INCY stock, worth $3,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$3,316% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
676Shares Held
186MCall Options Held
685KPut Options Held
533K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.04 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.42 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.3 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.01 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$700 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...